| Serial Number | 98069930 |
| Word Mark | WUXI XDC |
| Filing Date | Monday, July 3, 2023 |
| Status | 748 - STATEMENT OF USE - TO EXAMINER |
| Status Date | Thursday, February 20, 2025 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | Tuesday, December 5, 2023 |
| Goods and Services | Custom assembling of materials for others; custom manufacturing of pharmaceuticals; custom manufacturing of drug conjugates; custom production of pharmaceuticals; custom production of biological preparations; custom manufacturing of Antibody-drug Conjugates; custom manufacturing of chemical reagents; custom manufacturing of pharmaceutical preparations; custom manufacturing of biomedical preparations; custom manufacture of drug conjugates; processing of pharmaceutical preparations; processing or treating of chemical reagents; processing of antibody drugs; custom manufacturing of Antibody drugs; processing of biomedical preparations; processing of biotechnology drug |
| Description of Mark | The mark consists of the stylized wording "WuXi XDC", with "XDC" partially inside an incomplete oval outline that intersects with another incomplete oval outline. |
| Indication of Colors claimed | Color is not claimed as a feature of the mark. |
| Goods and Services | Development of products for others in the field of pharmaceuticals; pharmaceutical drug development services; research and development of new products in the field of pharmaceuticals; biochemical research and development; custom design and development of chemical reagent antibodies and conjugate antibodies; research and development in the pharmaceutical, biomedicine and biotechnology fields; research and development of antibodies; research and development of conjugated antibodies; biomedical research services; development of pharmaceutical preparations and medicines; research and development of antibody-drug conjugates; research and development of drug conjugates; preclinical research and evaluation of new drugs; consulting services in the field of technology development; research and development of new products for others; scientific research and development |
| International Class | 040 - Treatment of materials. |
| US Class Codes | 100, 103, 106 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, August 3, 2023 |
| Primary Code | 040 |
| First Use Anywhere Date | Thursday, March 9, 2023 |
| First Use In Commerce Date | Thursday, March 9, 2023 |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, August 3, 2023 |
| Primary Code | 042 |
| First Use Anywhere Date | Thursday, March 9, 2023 |
| First Use In Commerce Date | Thursday, March 9, 2023 |
| Party Name | WuXi XDC Cayman Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Grand Cayman KY1-1104 KY |
| Party Name | WuXi XDC Cayman Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Grand Cayman KY1-1104 KY |
| Event Date | Event Description |
| Thursday, July 6, 2023 | NEW APPLICATION ENTERED |
| Thursday, August 3, 2023 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Friday, August 4, 2023 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| Tuesday, October 31, 2023 | ASSIGNED TO EXAMINER |
| Wednesday, November 1, 2023 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Tuesday, December 5, 2023 | PUBLISHED FOR OPPOSITION |
| Wednesday, November 15, 2023 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, December 5, 2023 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, January 30, 2024 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Thursday, July 18, 2024 | SOU TEAS EXTENSION RECEIVED |
| Thursday, July 18, 2024 | SOU EXTENSION 1 FILED |
| Thursday, July 18, 2024 | SOU EXTENSION 1 GRANTED |
| Sunday, December 8, 2024 | USE AMENDMENT FILED |
| Sunday, December 8, 2024 | SOU EXTENSION 2 FILED |
| Sunday, December 8, 2024 | SOU TEAS EXTENSION RECEIVED |
| Thursday, February 20, 2025 | STATEMENT OF USE PROCESSING COMPLETE |
| Thursday, February 20, 2025 | SOU EXTENSION 2 GRANTED |
| Thursday, February 20, 2025 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| Friday, February 21, 2025 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Wednesday, July 24, 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Sunday, December 8, 2024 | TEAS STATEMENT OF USE RECEIVED |